Please ensure Javascript is enabled for purposes of website accessibility

Why InMode Shares Are Skyrocketing 14.7% Today

By Todd Campbell - Updated Sep 2, 2020 at 3:56PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The medical device maker announced a million-share repurchase program.

What happened

Shares of InMode (INMD -4.27%) were surging 14.7% at 3:30 p.m. EDT on Monday after management unveiled plans allowing it to repurchase up to 1 million shares in the open market.

So what

The healthcare company's medical devices are used to perform aesthetic treatments, including liposuction, using radio frequency energy to reduce scarring and decrease recovery times. 

A man in a suit speaking through a megaphone.

Image source: Getty Images.

Following robust growth last year, including a 56% jump in revenue to $156.4 million, demand for InMode's solutions has sagged this year because of COVID-19 restrictions.

In Q2, a drop in procedure volume caused revenue to decline 20.7% year over year to $30.8 million, contributing to GAAP earnings per share falling to $0.21 from $0.45 in the same quarter last year. Because of slowing sales, InMode's shares were down 21% year to date through Tuesday.

Apparently, management thinks the decline in its shares is overdone. On Wednesday, its board of directors approved a share repurchase program of up to 1 million shares, citing new product launches, a gradual return of elective surgeries, and its shares being "an attractive investment opportunity."

Now what

There's no guarantee or requirement that InMode buys any shares back under this new program. Nevertheless, a willingness to repurchase shares suggests management is confident procedure growth will bounce back and profitability will improve.

That's particularly encouraging given management indicated there was virtually no demand in March, procedure volume was still treading water in May, and was just in line with pre-COVID levels in June.

 

Todd Campbell has no position in any of the stocks mentioned. His clients may have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

InMode Ltd. Stock Quote
InMode Ltd.
INMD
$32.51 (-4.27%) $-1.45

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
397%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.